8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Clinical trial NCT01451827 · COMPLETED
Trial details
- NCT number
- NCT01451827
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-07-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.